Translate
Orchestra Biomed Holdings Inc.
About
Orchestra Biomed Holdings Inc. (NASDAQ:OBIO) — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 12 2026
Orchestra BioMed Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update
Mar 3 2026
Orchestra BioMed Announces Presentations Highlighting AVIM Therapy Potential Impact on Hypertensive Heart Disease and Heart Failure at THT and CRT
Feb 13 2026
Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jan 12 2026
Orchestra BioMed to Receive Up to $21 Million in Proceeds from Acquisition of Vivasure by Haemonetics
Dec 8 2025
Orchestra BioMed Announces AVIM Therapy and Virtue SAB Program Presentations at ICI Meeting